Effects of L-carnitine on Blood Lipid Metabolism and Antioxidation in Hyperlipidemia Rats
Guihua Wang
Abstract
Guihua Wang
Abstract
[Objective] To study the effects of L-carnitine (LC) on lowering the high blood lipid and antioxidation in hyperlipidemia rats. [Method] 50 healthy SD rats were randomly divided into 5 groups. They were fed with standard diet, high-cholesterol diet and high-cholesterol diet with 0.25, 0.5, 1.0 g/(kg·d) LC. After the LC groups were consecutively orally administered LC for 28 days, rat serum total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL-C), low density lipoprotein (LDL-C) content, as well as super oxide dismutase (SOD) activity and malondialdehyde (MDA) content in serum and liver were determined. [Result] Compared with the high-fat model group, LC could significantly reduce the serum TC, TG, LDL-C levels, increase HDL-C level, and enhance SOD activity in serum and liver, decrease the content of MDA (P0.05). [Conclusion] LC might have a significant role in lowering the high blood lipid and improving internal antioxidant capacity in hyperlipidemia rats.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
[Objective] To study the effects of L-carnitine (LC) on lowering the high blood lipid and antioxidation in hyperlipidemia rats. [Method] 50 healthy SD rats were randomly divided into 5 groups. They were fed with standard diet, high-cholesterol diet and high-cholesterol diet with 0.25, 0.5, 1.0 g/(kg·d) LC. After the LC groups were consecutively orally administered LC for 28 days, rat serum total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL-C), low density lipoprotein (LDL-C) content, as well as super oxide dismutase (SOD) activity and malondialdehyde (MDA) content in serum and liver were determined. [Result] Compared with the high-fat model group, LC could significantly reduce the serum TC, TG, LDL-C levels, increase HDL-C level, and enhance SOD activity in serum and liver, decrease the content of MDA (P0.05). [Conclusion] LC might have a significant role in lowering the high blood lipid and improving internal antioxidant capacity in hyperlipidemia rats.
Key concepts: Hyperlipidemia, Malondialdehyde, Triglyceride, Carnitine, Chemistry, Endocrinology, Internal medicine, High-density lipoprotein